Payton Claire Schmidt, MD | |
1500 E Medical Center Dr, Ann Arbor, MI 48109-5000 | |
(734) 936-4000 | |
Not Available |
Full Name | Payton Claire Schmidt |
---|---|
Gender | Female |
Speciality | Obstetrics/gynecology |
Experience | 10 Years |
Location | 1500 E Medical Center Dr, Ann Arbor, Michigan |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1760895973 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | 4301105836 (Michigan) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
University Of Michigan Health System | Ann arbor, MI | Hospital |
Midmichigan Medical Center-midland | Midland, MI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Mymichigan Medical Center Midland | 2264323633 | 338 |
Regents Of The University Of Michigan | 3779496856 | 2953 |
News Archive
When it comes to the federal budget, the public is on a different page than either the House of Representatives or the Obama Administration - with a different set of priorities and a greater willingness to cut spending and increase taxes - concludes a new analysis by the University of Maryland's Program for Public Consultation.
CANCER RESEARCH UK and the Netherlands Cancer Institute have completed the first stage of a landmark initiative to systematically uncover the function of our genes, the charities announce today.
EpiCept Corporation announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Ceplene® (histamine dihydrochloride). EpiCept is seeking approval for Ceplene, administered concomitantly with low-dose interleukin-2 (IL-2), for the remission maintenance and prevention of relapse in patients with Acute Myeloid Leukemia (AML) in first complete remission.
Testing for genetic mutations beyond those medically recommended is unlikely to prevent the birth of children with classic cystic fibrosis and may detect mutations causing only mild disease, according to a study published online in Genetics in Medicine, the official publication of the American College of Medical Genetics (ACMG).
› Verified 6 days ago
Entity Name | Regents Of The University Of Michigan |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1942235163 PECOS PAC ID: 3779496856 Enrollment ID: O20031117000778 |
News Archive
When it comes to the federal budget, the public is on a different page than either the House of Representatives or the Obama Administration - with a different set of priorities and a greater willingness to cut spending and increase taxes - concludes a new analysis by the University of Maryland's Program for Public Consultation.
CANCER RESEARCH UK and the Netherlands Cancer Institute have completed the first stage of a landmark initiative to systematically uncover the function of our genes, the charities announce today.
EpiCept Corporation announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Ceplene® (histamine dihydrochloride). EpiCept is seeking approval for Ceplene, administered concomitantly with low-dose interleukin-2 (IL-2), for the remission maintenance and prevention of relapse in patients with Acute Myeloid Leukemia (AML) in first complete remission.
Testing for genetic mutations beyond those medically recommended is unlikely to prevent the birth of children with classic cystic fibrosis and may detect mutations causing only mild disease, according to a study published online in Genetics in Medicine, the official publication of the American College of Medical Genetics (ACMG).
› Verified 6 days ago
Entity Name | Mymichigan Medical Center Midland |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1205889490 PECOS PAC ID: 2264323633 Enrollment ID: O20040324000137 |
News Archive
When it comes to the federal budget, the public is on a different page than either the House of Representatives or the Obama Administration - with a different set of priorities and a greater willingness to cut spending and increase taxes - concludes a new analysis by the University of Maryland's Program for Public Consultation.
CANCER RESEARCH UK and the Netherlands Cancer Institute have completed the first stage of a landmark initiative to systematically uncover the function of our genes, the charities announce today.
EpiCept Corporation announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Ceplene® (histamine dihydrochloride). EpiCept is seeking approval for Ceplene, administered concomitantly with low-dose interleukin-2 (IL-2), for the remission maintenance and prevention of relapse in patients with Acute Myeloid Leukemia (AML) in first complete remission.
Testing for genetic mutations beyond those medically recommended is unlikely to prevent the birth of children with classic cystic fibrosis and may detect mutations causing only mild disease, according to a study published online in Genetics in Medicine, the official publication of the American College of Medical Genetics (ACMG).
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Payton Claire Schmidt, MD 3621 S State St, Ann Arbor, MI 48108-1633 Ph: (734) 647-5299 | Payton Claire Schmidt, MD 1500 E Medical Center Dr, Ann Arbor, MI 48109-5000 Ph: (734) 936-4000 |
News Archive
When it comes to the federal budget, the public is on a different page than either the House of Representatives or the Obama Administration - with a different set of priorities and a greater willingness to cut spending and increase taxes - concludes a new analysis by the University of Maryland's Program for Public Consultation.
CANCER RESEARCH UK and the Netherlands Cancer Institute have completed the first stage of a landmark initiative to systematically uncover the function of our genes, the charities announce today.
EpiCept Corporation announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Ceplene® (histamine dihydrochloride). EpiCept is seeking approval for Ceplene, administered concomitantly with low-dose interleukin-2 (IL-2), for the remission maintenance and prevention of relapse in patients with Acute Myeloid Leukemia (AML) in first complete remission.
Testing for genetic mutations beyond those medically recommended is unlikely to prevent the birth of children with classic cystic fibrosis and may detect mutations causing only mild disease, according to a study published online in Genetics in Medicine, the official publication of the American College of Medical Genetics (ACMG).
› Verified 6 days ago
Evangelia Lea Lazaris, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Olivia Winfrey, Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Dr. Ellery Grace Sarosi, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Joanne Vicari Block, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4350 Jackson Rd Ste 300, Ann Arbor, MI 48103 Phone: 734-995-2259 Fax: 734-995-2418 | |
Aisha Yousuf, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1500 East Medical Center Drive, L4100 Womens, Ann Arbor, MI 48109 Phone: 734-936-9434 Fax: 734-647-1006 | |
Dr. Edwin Peter Peterson, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 375 W Northfield Church Rd, Ann Arbor, MI 48105 Phone: 734-663-1705 Fax: 734-663-1302 | |
Dr. Ashley Mia Dowgiert, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4350 Jackson Rd, Suite 300, Ann Arbor, MI 48103 Phone: 734-995-2259 Fax: 734-995-2418 |